Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Most HPV infections are harmless and resolve on their own, but certain high-risk strains can lead to cervical cancer and other malignancies if left undetected.

This guide explains how to read your HPV test results, what different findings mean, and what steps to take based on your results.

Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

What Is HPV?

Human papillomavirus (HPV) is a large family of over 200 related viruses. They are classified into two main groups based on their cancer-causing potential:

Low-risk HPV types (e.g., types 6, 11) — cause genital warts and other benign lesions. They do not cause cancer.
High-risk HPV types (e.g., types 16, 18, 31, 33, 45, 52, 58) — can cause persistent infections that, over years to decades, may lead to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers.

HPV types 16 and 18 alone are responsible for approximately 70% of all cervical cancers worldwide.

Key facts about HPV:

Extremely common: An estimated 80% of sexually active adults will contract HPV at some point in their lives.
Usually clears on its own: Over 90% of HPV infections are cleared by the immune system within 1–2 years without causing any health problems.
No symptoms in most cases: Most people with HPV never know they are infected.
Transmission: Primarily through skin-to-skin sexual contact. Condoms reduce but do not eliminate risk.

Types of HPV Tests

HPV DNA Test (PCR-Based)

The most common testing method uses PCR (polymerase chain reaction) technology to detect the genetic material (DNA) of HPV in cervical or other mucosal cells.

This test can identify:

Whether HPV is present (qualitative result: positive or negative).
Which specific HPV types are present (genotyping).
The viral load in some assays (quantitative result: number of viral copies).

HPV mRNA Test

Some newer tests detect HPV mRNA (E6/E7 oncogene activity) rather than DNA. A positive mRNA test suggests the virus is actively producing cancer-causing proteins, making it more specific for clinically significant infections.

Co-testing (HPV + Pap Smear)

Many screening programs combine HPV testing with a Pap smear (cervical cytology). This dual approach maximizes detection:

HPV test detects the presence of the virus.
Pap smear detects cellular changes (dysplasia) caused by the virus.

Understanding Your Results

HPV Negative

A negative HPV test means no high-risk HPV types were detected in your sample. This is a very reassuring result:

Risk of cervical precancer or cancer is extremely low for the next several years.
If your Pap smear is also normal, the recommended screening interval is typically every 5 years (for co-testing) according to current guidelines (ACS, ASCCP, USPSTF).

However, a negative result does not mean you are immune to HPV. Future infections can occur through new sexual exposures.

HPV Positive (Non-16/18 High-Risk Type)

A positive result for other high-risk HPV types (not 16 or 18) means a potentially cancer-causing strain was detected, but the risk is lower than with types 16 or 18.

Recommended next steps typically include:

If Pap smear is normal: Repeat co-testing in 12 months. Most of these infections will clear on their own.
If Pap smear shows abnormalities (ASC-US or worse): Colposcopy (a closer examination of the cervix with magnification and possible biopsy).

HPV 16 and/or 18 Positive

Detection of HPV type 16 or 18 carries the highest risk and requires the most proactive follow-up:

Colposcopy is recommended regardless of the Pap smear result, because these types have the greatest potential to cause cervical precancer and cancer.
Early detection and monitoring at this stage is extremely effective — cervical cancer is one of the most preventable cancers when caught early.

Understanding Viral Load (Quantitative Results)

Some HPV tests report a viral load — the number of viral copies detected (often expressed as copies/mL or Ct values).

High viral load may indicate a more persistent or clinically significant infection.
Low viral load often corresponds to a transient infection that the immune system is likely to clear.

However, viral load alone does not determine cancer risk. The type of HPV and the duration of infection are more important predictive factors.

HPV Genotyping: Why It Matters

Genotyping identifies which specific HPV type(s) you carry. This information is clinically important because:

Types 16 and 18 require more aggressive follow-up than other high-risk types.
Persistent infection with the same type over 12–24 months significantly increases risk and usually triggers a colposcopy referral.
Infection with a new type (different from a previous positive result) may represent a new infection rather than persistence.

Modern testing platforms can identify 14+ high-risk HPV types individually or in groups.

HPV and Cervical Cancer: The Timeline

It is critical to understand that HPV infection and cervical cancer are separated by a long timeline:

HPV infection — initial exposure (usually unnoticed).
Persistent infection — the virus is not cleared within 1–2 years (minority of cases).
Precancerous changes (CIN 1, 2, 3 / LSIL, HSIL) — abnormal cell changes detected on Pap smear or biopsy. This stage can last years to decades.
Invasive cervical cancer — occurs only if precancerous changes are not detected and treated. This typically takes 10–20 years from initial infection.

This long timeline is precisely why screening is so effective. When precancerous changes are detected and treated, progression to cancer is almost entirely preventable.

Screening Guidelines

Current international screening recommendations (ACS 2020, WHO 2021):

Age 21–24: Pap smear alone every 3 years (HPV testing not recommended in this age group due to high transient infection rates).
Age 25–29: HPV primary testing every 5 years (preferred), or co-testing every 5 years, or Pap alone every 3 years.
Age 30–65: HPV primary testing every 5 years (preferred), or co-testing every 5 years.
After age 65: Screening can be discontinued if prior results have been consistently negative.
After hysterectomy (with cervix removal): Screening is generally no longer needed unless the hysterectomy was performed for cervical precancer or cancer.

These are general guidelines — your doctor may recommend a different schedule based on your individual risk factors.

HPV in Men

While cervical cancer screening is the primary context for HPV testing, men are also affected:

HPV causes most cases of anal cancer, oropharyngeal (throat) cancer, and penile cancer in men.
There is currently no FDA-approved routine HPV screening test for men. Testing may be performed in specific clinical situations (e.g., anal Pap smears for high-risk men).
HPV vaccination is recommended for boys and men up to age 26 (and up to 45 on an individual basis) to prevent HPV-related cancers.

HPV Vaccination

The HPV vaccine is one of the most effective cancer prevention tools available:

Gardasil 9 protects against 9 HPV types (6, 11, 16, 18, 31, 33, 45, 52, 58), covering approximately 90% of cervical cancers and 90% of genital warts.
Recommended age: 9–14 years (2-dose schedule), catch-up through age 26 (3-dose schedule). Shared decision-making for ages 27–45.
Effectiveness: Near 100% protection against targeted types in individuals who have not yet been exposed.
Vaccination does not treat existing HPV infections — it prevents new infections with the covered types.

Even vaccinated individuals should continue recommended screening, as the vaccine does not cover all high-risk HPV types.

Frequently Asked Questions

Can HPV be cured? There is no treatment that eliminates the virus itself. However, the immune system clears most infections naturally. Treatments are available for the conditions HPV causes (warts, precancerous lesions).

Does a positive HPV test mean I have cancer? No. A positive test means the virus is present. It does not mean cancer is present. Most HPV infections never lead to cancer.

Should my partner be tested? Routine HPV testing is not available for men. Since HPV is extremely common and usually harmless, a positive test in one partner does not necessarily indicate recent infidelity — the infection may have been acquired years ago.

Related Tests

HPV screening results are most meaningful in the context of your overall health:

Complete blood count — immune function markers.
Urinalysis — urinary tract health.
Thyroid panel — hormonal health, especially relevant for women.
Blood chemistry panel — overall metabolic health.

Key Takeaways

A positive HPV test is not a cancer diagnosis — it is a signal to monitor more closely.
HPV types 16 and 18 carry the highest risk and warrant prompt follow-up with colposcopy.
Most HPV infections clear naturally within 1–2 years thanks to the immune system.
Regular screening is the most effective way to prevent cervical cancer — it detects precancerous changes years before they can become dangerous.
HPV vaccination is safe, highly effective, and recommended for both boys and girls starting at age 9–14.

Get Your Test Results Interpreted

Understanding your lab results is key to making informed health decisions. If you have HPV test results, a Pap smear, or any other lab report and want a clear, personalized explanation, upload your results at Evallume for an instant AI-powered interpretation.

This article is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Consult a healthcare professional for any medical concerns.

HPV Test Interpretation: Understanding Your Screening Results

Upload your tests